| abstract |
The present invention generally relates to a method of manufacturing a formulation for delivering a biological agent to a patient. In one aspect, a pharmaceutical proliposomal drug-delivery system is provided. In another aspect, a coated proliposome-type formulation for a low water-soluble drug and a method for producing the same are provided. Certain embodiments of the present invention provide increased stability and bioavailability of pharmaceutical formulations. |